Effectiveness of <scp>SARS‐CoV</scp> ‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study-Reference-Cited by-同舟云学术

Effectiveness of SARS‐CoV ‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study

Published:2022-06-14 Issue:1 Volume:27 Page:19-23
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Kikuchi Kan¹,Nangaku Masaomi²,Ryuzaki Munekazu³,Yamakawa Tomoyuki⁴,Yoshihiro Ota⁵,Hanafusa Norio⁶,Sakai Ken⁷,Kanno Yoshihiko⁸,Ando Ryoichi⁹,Shinoda Toshio¹⁰,Wakino Shu¹¹,Nakamoto Hidetomo¹²,Takemoto Yoshiaki¹³,Akizawa Tadao¹⁴^ORCID,

Affiliation:

1. Division of Nephrology Shimoochiai Clinic Tokyo Japan

2. Division of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo Japan

3. Department of Nephrology Tokyo Saiseikai Central Hospital Tokyo Japan

4. Kidney Center Shirasagi Hospital Tokyo Japan

5. Nagoya Memorial Hospital Nagoya Japan

6. Department of Blood Purification Tokyo Women's Medical University Tokyo Japan

7. Department of Nephrology Toho University Faculty of medicine Tokyo Japan

8. Department of Nephrology Tokyo Medical University Tokyo Japan

9. Department of Nephrology Seishokai Memorial Hospital Tokyo Japan

10. Faculty of Medical and Health Sciences Tsukuba International University Tsukuba Japan

11. Department of Nephrology Institute of Biomedical Sciences, Tokushima University Graduate School Tokushima Japan

12. Department of General Internal Medicine Saitama Medical University Saitama Japan

13. Department of Urology, Graduate School of Medicine Shirasagi Hospital Osaka City University Osaka Japan

14. Division of Nephrology, Department of Medicine Showa University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13887

Reference11 articles.

1. World Health Organization(WHO).Coronavirus disease (COVID‐19) Pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed January 15 2022.

2. The Japanese Ministry of Health Labour and Welfare.Current status of COVID‐19 in the general population in Japan (as of January 16 2022). [in Japanese].https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html. Accessed January 17 2022.

3. COVID‐19 Task Force Committee of the Japanese Association of Dialysis Physicians the Japanese Society for Dialysis Therapy and the Japanese Society of Nephrology.Current status of COVID‐19 in the dialysis patients in Japan (as of January 13 2022). [in Japanese].https://jsn.or.jp/medic/data/COVID-19number-of-infected_20220114.pdf. Accessed January 17 2022.

4. COVID ‐19 of dialysis patients in Japan: Current status and guidance on preventive measures

5. Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalization and mortality during the pandemic in chronic hemodialysis patients and the general population in Peru;Brazilian Journal of Nephrology;2023-12

2. Hospitalizations for non‐SARS‐CoV‐2 respiratory infectious diseases among patients on hemodialysis: A comparison before and during the coronavirus disease 2019 pandemic;Therapeutic Apheresis and Dialysis;2023-10-31

3. Infection prevention measures for patients on hemodialysis during COVID-19 pandemic in Japan: a nationwide questionnaire follow-up survey in 2022;Renal Replacement Therapy;2023-10-20

4. Effectiveness of vaccination in reducing hospitalization and mortality rates in dialysis patients with Omicron infection in China: A single-center study;Human Vaccines & Immunotherapeutics;2023-08

5. Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID‐19 in clinical practice during the Omicron (BA.1 and BA.2) pandemic;Therapeutic Apheresis and Dialysis;2023-07-03